Remarkably, 52% of newly diagnosed and 81% of relapsed MM patients have shown an increase in Mcl-1 protein expression, which correlates with disease progression and a poor patient survival rate [19]. This evidence concerns the gene MCL1 and Miyoshi myopathy.